WILMINGTON, N.C., (May 3, 2016) – Pharmaceutical Product Development, LLC (PPD) today announced it has been named for the fifth time to the InformationWeek Elite 100, a list of the top business technology innovators in the United States.
“PPD’s recognition validates our commitment to accelerating the pace of innovation in research and harnessing new and innovative approaches to help speed the delivery of life-changing therapies,” said Mike Wilkinson, executive vice president and chief information officer for PPD. “PPD helps our clients build a global approach to clinical trials and technology that better engages and encourages patient participation in clinical trials.”
PPD’s technology features disruptive innovations, including utilizing wearable or mHealth technology, and Preclarus®, PPD’s portfolio of solutions that consolidates and standardizes clinical trial data from multiple sources, giving clients transparent, real-time access to all clinical trial operations and patient data.
“As business success becomes even more dependent on the ability to innovate in information technology, being represented on the InformationWeek Elite 100 list is one of the biggest honors a company can achieve,” said Susan Nunziata, editorial director of InformationWeek magazine. “It’s a validation of efforts by the business to make IT a game changer.”
InformationWeek identifies and honors the nation's most innovative users of information technology. The InformationWeek Elite 100 research tracks the technology-based investments, strategies and results of some of the best-known organizations in the country, spotlighting the power of business technology innovation.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 15,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.
+1 910 558 6096
+1 910 558 6783